Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells.

[1]  Xiao-yong Lei,et al.  Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells. , 2007, Acta biochimica et biophysica Sinica.

[2]  H. Lincet,et al.  Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells. , 2007, Gynecologic oncology.

[3]  A. Mandelin,et al.  Myeloid cell leukemia-1 as a therapeutic target , 2007, Expert opinion on therapeutic targets.

[4]  H. Xin,et al.  Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA. , 2006, Cancer research.

[5]  S. Kridel,et al.  Fatty acid synthase: a novel target for antiglioma therapy , 2006, British Journal of Cancer.

[6]  Wei Li,et al.  The role of cell cycle regulatory proteins in the pathogenesis of melanoma , 2006, Pathology.

[7]  Yi Chen,et al.  Growth arrest induced by C75, A fatty acid synthase inhibitor, Was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma , 2006, Cancer biology & therapy.

[8]  R. Dhir,et al.  Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma. , 2006, Human pathology.

[9]  J. Menéndez,et al.  Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  J. Swinnen,et al.  RNA Interference–Mediated Silencing of the Acetyl-CoA-Carboxylase-α Gene Induces Growth Inhibition and Apoptosis of Prostate Cancer Cells , 2005 .

[11]  J. Menéndez,et al.  Targeting fatty acid synthase: potential for therapeutic intervention in her-2/neu-overexpressing breast cancer. , 2005, Drug news & perspectives.

[12]  J. Menéndez,et al.  Pharmacological and small interference RNA‐mediated inhibition of breast cancer‐associated fatty acid synthase (oncogenic antigen‐519) synergistically enhances Taxol (paclitaxel)‐induced cytotoxicity , 2005, International journal of cancer.

[13]  E. Jaffee,et al.  Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice , 2005, Oncogene.

[14]  M. Ranson,et al.  Apoptosis pathway-targeted drugs--from the bench to the clinic. , 2004, Biochimica et biophysica acta.

[15]  J. Menéndez,et al.  Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells. , 2004, Oncology reports.

[16]  S. Ropero,et al.  Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Menéndez,et al.  Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells , 2004, Oncogene.

[18]  S. Ariyan,et al.  Her2/neu is not a commonly expressed therapeutic target in melanoma – a large cohort tissue microarray study , 2004, Melanoma research.

[19]  R. Lotan,et al.  Apoptosis as a novel target for cancer chemoprevention. , 2004, Journal of the National Cancer Institute.

[20]  Jeffrey W. Smith,et al.  Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity , 2004, Cancer Research.

[21]  J. Menéndez,et al.  Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. , 2004, International journal of oncology.

[22]  J. Swinnen,et al.  RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. , 2003, Cancer research.

[23]  H. Pehamberger,et al.  Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model. , 2003, The Journal of investigative dermatology.

[24]  K. David,et al.  Key role of mitochondria in cerulenin-mediated apoptosis , 2002, Cell Death and Differentiation.

[25]  V. Anderson,et al.  Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells , 2002, Cancer Chemotherapy and Pharmacology.

[26]  C. Dive,et al.  Apoptosis and cancer chemotherapy. , 2001, Trends in cell biology.

[27]  M. V. Vander Heiden,et al.  Bcl-x l Promotes the Open Configuration of the Voltage-dependent Anion Channel and Metabolite Passage through the Outer Mitochondrial Membrane* , 2001, The Journal of Biological Chemistry.

[28]  G. Muir,et al.  Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray , 2001, British Journal of Cancer.

[29]  M. Gorospe,et al.  Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. , 2001, Cancer research.

[30]  C. Townsend,et al.  Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. , 2000, Cancer research.

[31]  J. Segall,et al.  The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. , 1999, Endocrine reviews.

[32]  G. Pasternack,et al.  Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. , 1996, Cancer research.

[33]  P. Visca,et al.  Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients , 1996, Cancer.

[34]  S. Kakabakos,et al.  Direct colorimetric determination of solid-supported functional groups and ligands using bicinchoninic acid. , 1994, Analytical biochemistry.

[35]  S. Ōmura.  The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. , 1976, Bacteriological reviews.